Lastly, miR-126a-3p has also a regulatory role for the expression of CXCL12 via the inhibition of CXCR4 by RGS16, a signaling pathway that is involved in atherosclerosis and inflammation [52]. Here, CXCL12 is linked to atherosclerosis.